SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-19-243978
Filing Date
2019-09-12
Accepted
2019-09-12 17:02:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d804097d424b3.htm 424B3 222724
2 GRAPHIC g751823g73u99.jpg GRAPHIC 38276
  Complete submission text file 0001193125-19-243978.txt   276551
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-233537 | Film No.: 191090912
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences